+7 (701) 759 90 19
USD 405.69 EUR 455.51
RUB 5.72 CNY 57.42
News

Russia’s coronavirus vaccine tested on monkeys, hamsters

3 June 2020 17:34
Share in:
Russia’s coronavirus vaccine tested on monkeys, hamsters

MOSCOW. KAZINFORM Pre-clinical trials of the coronavirus vaccine on monkeys and hamsters have proven its safety and effectiveness, Head of the 48th Central Research Institute of the Russian Defense Ministry Sergey Borisevich said.

Related news
Turkey temporary suspends entry for Kazakhstan citizens Aktobe converts university's dormitory into 600-bed hospital Almaty city received 12.2bn tenge to fight COVID-19

«As part of pre-clinical research the specialists of the 48th Central Research Institute of the Russian Defense Ministry successfully completed the trials on two species of animals: monkeys and hamsters. During the research, the safety of the medication and its protective effectiveness were shown and proven,» Borisevich told Krasnaya Zvezda (Red Star) newspaper, TASS reports.

The Russian Defense Ministry reported that 50 volunteers among the servicemen had been selected to conduct the vaccine trials on humans. These are 45 men and five women aged between 25 and 50, who are healthy and without bad habits.

The head of the Main Military Clinical Burdenko Hospital, Evgeny Kryukov, said among the volunteers were ten medical staff, including three doctors. Before the trials begin, they will be isolated and pass tests for the coronavirus. The goal of the clinical trials is to confirm whether the vaccine is safe and people tolerate it well and whether a human body can develop protective anti-bodies to the novel coronavirus infection, he said.

Russian Defense Minister Sergei Shoigu earlier told President Vladimir Putin that the 48th Central Research Institute of the Russian Defense Ministry jointly with the Gamaleya National Research Institute of Epidemiology and Microbiology were developing a recombinant coronavirus vaccine. According to Shoigu, clinical trials were to be completed by the end of July.

The clinical trials of the vaccine will be conducted at the 48th Central Research Institute of the Russian Defense Ministry where vaccines against Ebola and Middle East Respiratory Syndrome (MERS), as well as a universal flu vaccine, had been studied and successfully tested.



Share in:
+7
Send
Employees online
Editor
Nurmaganbetova Zhanna
Nurmaganbetova Zhanna
954-048
Editor
Kudrenok Tatyana
Kudrenok Tatyana
954-048

Archive